PELTHOS THERAPEUTICS INC (PTHS) Stock Analyst Ratings
NYSEARCA:PTHS • US1711262048
26.36 USD
+3.36 (+14.61%)
Last: Feb 27, 2026, 08:27 PM
ChartMill assigns a Buy % Consensus number of 84% to PTHS. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 61.61. This target is 133.72% above the current price.
- PTHS was analyzed by 11 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about PTHS.
- In the previous month the buy percentage consensus was at a similar level.
- PTHS was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-27 | Piper Sandler | Initiate | Overweight |
| 2026-02-26 | Roth Capital | Maintains | Buy -> Buy |
| 2026-01-26 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-12-03 | Lake Street | Initiate | Buy |
| 2025-12-03 | HC Wainwright & Co. | Initiate | Buy |
| 2025-11-25 | Roth Capital | Initiate | Buy |
| 2025-11-14 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2025-09-02 | Oppenheimer | Initiate | Outperform |
PELTHOS THERAPEUTICS INC / PTHS FAQ
What is the average price target for PELTHOS THERAPEUTICS INC (PTHS) stock?
11 analysts have analysed PTHS and the average price target is 61.61 USD. This implies a price increase of 133.72% is expected in the next year compared to the current price of 26.36.
What is the consensus rating for PELTHOS THERAPEUTICS INC (PTHS) stock?
The consensus rating for PELTHOS THERAPEUTICS INC (PTHS) is 83.6364 / 100 . This indicates that analysts generally have a positive outlook on the stock.